Efficacy of Oral Tapentadol IR for Management of Moderate to Severe Cancer Pain in Patients Presenting in Oncology Ward at JPMC, Karachi
A starting dose of 75 mg BID of tapentadol IR led to a significant pain reduction in cancer patients with chronic pain in the Pakistani population, regardless of previous analgesic intake or cancer type.
Authors
- Hareem Akhtar
- Ammara Manzoor
- Sana Nasir
- Saima Zahoor
- Hina Gul
Institutions
- Jinnah Postgraduate Medical Center (PK)
- National Institute Of Blood Disease and Bone Marrow Transplantation (PK)
Publication Details
- Journal
- Pakistan Journal of Medical Sciences
- Published
- 2026-01-05
- DOI
- https://doi.org/10.12669/pjms.42.1.12885
- Primary Topic
- Pain Management and Opioid Use
- Type
- article
- Field-Weighted Citation Impact
- 0.00